DXCM
NASD DexCom, Inc.$84.97 ↑ +0.56 (+0.66%) Trading Up from the previous close of $84.41
- YTD change
- +28.02%
- vs 20-day SMA
- -1.74%
- vs 200-day SMA
- +15.72%
Price ranges
Price & Performance
+18.73 (+28.52%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 48.5% away from all-time highs of $164.86
- DXCM is up 28% since the beginning of the year
- DXCM is up 25% over the past 12 months
- DXCM is up 1% over the past 1 month
- 5% of all DXCM investors are betting against DXCM
DXCM reads very good: price sits above one of the two key moving averages, the 12-month move is +24.0%.
- Previous minute
- +$0.47
- Last hour
- +$0.47
- Last 5 days
- -1.46%
- vs 8-day SMA
- -0.55%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.